ARGX:NASDAQ
argenx SE - ADR
$981.33
arrow_upward
+0.38%(+3.75) 1D
$981.33
0.00% (0.00)
bedtimeAfter hours
Closed: Nov 12, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
$976.89
High
$988.89
Low
$964.86
Mkt. cap
61.69B
Avg. vol.
468.70K
Volume
0.00
P/E ratio
33.91
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$28.94
Beta
0.48
Shares outstanding
62.89M
No. of employees
2K
Open
$976.89
High
$988.89
Low
$964.86
Mkt. cap
61.69B
Avg. vol.
468.70K
Volume
0.00
P/E ratio
33.91
52-wk high
$1,072.75
52-wk low
$661.85
EPS
$28.94
Beta
0.48
Shares outstanding
62.89M
No. of employees
2K
News stories
From web sources and news partners
Investing.com Canada
·
2 days ago
argenx at 3rd Annual Guggenheim Healthcare Innovation Conference: growth broadens
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE - ADR
CEO-
Employees1.86K
FoundedApr 25, 2008
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websiteargenx.com